Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).

Jett JR, Schild SE, Keith RL, Kesler KA; American College of Chest Physicians.

Chest. 2007 Sep;132(3 Suppl):266S-276S.

PMID:
17873173
2.

Guidelines on treatment of stage IIIB non-small cell lung cancer.

Jett JR, Scott WJ, Rivera MP, Sause WT; American College of Chest Physicians.

Chest. 2003 Jan;123(1 Suppl):221S-225S. Review.

PMID:
12527581
3.

A systematic overview of chemotherapy effects in non-small cell lung cancer.

Sörenson S, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):327-39. Review.

PMID:
11441939
4.

Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.

Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M; Eastern Cooperative Oncology Group.

J Clin Oncol. 2005 Jun 1;23(16):3760-7. Epub 2005 Apr 18. Review.

PMID:
15837967
5.

Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.

Ramalingam S, Belani C.

Oncologist. 2008;13 Suppl 1:5-13. doi: 10.1634/theoncologist.13-S1-5. Review.

6.
7.
8.

[Treatment of the unresectable non small cell lung carcinoma].

Spásová I.

Cas Lek Cesk. 2005;144(9):602-12; discussion 612-3. Review. Czech.

PMID:
16193938
9.

Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.

Chu Q, Vincent M, Logan D, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

Lung Cancer. 2005 Dec;50(3):355-74. Epub 2005 Aug 31. Review.

PMID:
16139391
10.

First-line treatment for advanced non-small-cell lung cancer.

Laskin JJ, Sandler AB.

Oncology (Williston Park). 2005 Nov;19(13):1671-6; discussion 1678-80. Review.

11.
12.

Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer.

Rosell R, Felip E.

Semin Oncol. 2001 Aug;28(4 Suppl 14):37-44. Review.

PMID:
11605182
13.

Advances in chemotherapy of non-small cell lung cancer.

Molina JR, Adjei AA, Jett JR.

Chest. 2006 Oct;130(4):1211-9. Review.

PMID:
17035458
14.

Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer.

Ulahannan SV, Brahmer JR.

Cancer Invest. 2011 May;29(4):325-37. doi: 10.3109/07357907.2011.554476. Review.

15.

Combination of standard chemotherapy and targeted agents.

Bareschino MA, Morgillo F, Ciardiello F.

J Thorac Oncol. 2007 May;2(5 Suppl):S19-23. Review. No abstract available.

16.

Current Standards and Clinical Trials in Systemic Therapy for Stage III Lung Cancer: What Is New?

Hanna N.

Am Soc Clin Oncol Educ Book. 2015:e442-7. doi: 10.14694/EdBook_AM.2015.35.e442. Review.

17.

Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literature.

Cardenal F, Nadal E, Jové M, Faivre-Finn C.

Ann Oncol. 2015 Feb;26(2):278-88. doi: 10.1093/annonc/mdu229. Epub 2014 Jun 18. Review.

PMID:
24942274
18.

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer.

Nieder C, Pawinski A, Dalhaug A, Andratschke N.

Radiat Oncol. 2012 Jan 11;7:3. doi: 10.1186/1748-717X-7-3. Review.

19.

Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions.

Vallejo Ocańa C, Garrido López P, Muguruza Trueba I.

Clin Transl Oncol. 2011 Sep;13(9):629-35. Review.

PMID:
21865134
20.

Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer.

Provencio M, Sánchez A.

Transl Lung Cancer Res. 2014 Apr;3(2):89-94. doi: 10.3978/j.issn.2218-6751.2014.03.06. Review.

Supplemental Content

Support Center